These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity]. Albert J, Ekoé JM. Sem Hop; 1983 Sep 01; 59(29-30):2135-40. PubMed ID: 6312587 [Abstract] [Full Text] [Related]
13. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats. Cam MC, Brownsey RW, Rodrigues B, McNeill JH. Metabolism; 2001 Jun 01; 50(6):674-80. PubMed ID: 11398144 [Abstract] [Full Text] [Related]
14. Postreceptor regulation of insulin action in primary cultures of rat hepatocytes by oral hypoglycemic agents: effects of linogliride and chlorpropamide. Salhanick AI, Leighty SJ, Amatruda JM. Horm Metab Res; 1989 Nov 01; 21(11):596-601. PubMed ID: 2687145 [Abstract] [Full Text] [Related]
16. Oral hypoglycemic agents in the treatment of type II diabetes. Tal A. Am Fam Physician; 1993 Nov 01; 48(6):1089-95. PubMed ID: 8237731 [Abstract] [Full Text] [Related]